Transthyretin Cardiac Amyloidosis clinical trials

Explore recruiting transthyretin cardiac amyloidosis clinical trials.

Recruiting transthyretin cardiac amyloidosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Transthyretin Cardiac Amyloidosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

HeArt Rate and quality of Life in transthyrEtin cardiac amYloidosis (HARLEY)

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Exploratory study evaluating the relevance of [68Ga]Ga-FAPI-46 for staging and identifying progressing patients with transthyretin cardiac amyloidosis

France

Therapeutic exploratory (Phase II) EU CTIS Study details

MAGNETICAL - MAGNetic resonance Evaluation of Tafamidis Impact in Cardiac AmyLoidosis

Portugal

Therapeutic use (Phase IV) EU CTIS Study details

Effect of pharmacological treatment with angiotensin receptor/neprilysin inhibitors on transthyretin cardiac amyloidosis and heart failure with reduced ejection fraction (SAVA-TTR trial)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Effect of dapagliflozin on the quality of life and exercise capacity of patients with amyloid transthyretin cardiac amyloidosis: a pilot, phase 2b study

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Transthyretin Cardiac Amyloidosis trials by city

Transthyretin Cardiac Amyloidosis in Toronto Transthyretin Cardiac Amyloidosis in Vancouver Transthyretin Cardiac Amyloidosis in Montreal Transthyretin Cardiac Amyloidosis in Calgary Transthyretin Cardiac Amyloidosis in Edmonton Transthyretin Cardiac Amyloidosis in Ottawa Transthyretin Cardiac Amyloidosis in Winnipeg Transthyretin Cardiac Amyloidosis in Quebec City Transthyretin Cardiac Amyloidosis in Hamilton Transthyretin Cardiac Amyloidosis in Kitchener Transthyretin Cardiac Amyloidosis in London Transthyretin Cardiac Amyloidosis in Halifax Transthyretin Cardiac Amyloidosis in New York Transthyretin Cardiac Amyloidosis in Los Angeles Transthyretin Cardiac Amyloidosis in Chicago Transthyretin Cardiac Amyloidosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease